These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14150250)

  • 41. Vascular distribution of experimental hepatomas.
    Matsumura H
    Nihon Geka Hokan; 1965 Jul; 34(4):974-96. PubMed ID: 4283954
    [No Abstract]   [Full Text] [Related]  

  • 42. Conversion of unresectable hepatoma to resectable. Report of a case and review of the literature.
    Tepetes KN; Tsamandas AC; Felekouras ES; Salakou SG; Karavias DD
    Hepatogastroenterology; 2000; 47(34):1105-9. PubMed ID: 11020889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. THE USE OF RAT ASCITES TUMORS HETEROGRAFTED IN MICE FOR SCREENING OF ANTICANCEROUS AGENTS.
    HAGIHARA K
    Acta Pathol Jpn; 1963 Oct; 13():295-307. PubMed ID: 14195195
    [No Abstract]   [Full Text] [Related]  

  • 44. [Isolation of precipitating antibodies to specific antigens of the liver and mouse hepatoma].
    ABELEV GI; AVENIROVA ZA
    Vopr Onkol; 1960; 6(6)():57-62. PubMed ID: 13791448
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapeutic approaches to hepatoma.
    Falkson G
    Cancer Treat Rev; 1975 Mar; 2(1):73-6. PubMed ID: 171068
    [No Abstract]   [Full Text] [Related]  

  • 46. [EXPERIMENTAL ANTICANCER STUDIES. 23. FURTHER EXPERIMENTS ON THE ANTITUMOR ACTIVITY OF 4-AMINO-6-OCTYLRESORCINOL HYDROCHLORIDE].
    KOSHIURA R; KOSHIMURA S; BANDO Y
    Gan; 1964 Oct; 55():433-41. PubMed ID: 14247592
    [No Abstract]   [Full Text] [Related]  

  • 47. Augmentation of tumor-specific immunogenicity by concanavalin A in the Morris hepatoma 5123.
    Enker WE; Craft K; Wissler RW
    J Surg Res; 1974 Jan; 16(1):66-8. PubMed ID: 4131863
    [No Abstract]   [Full Text] [Related]  

  • 48. [Approaches for interventional therapy of hepatoma].
    Guan YS; Yang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):785. PubMed ID: 16248956
    [No Abstract]   [Full Text] [Related]  

  • 49. Novel strategies for hepatocellular carcinoma based on MMPs science.
    Okazaki I; Inagaki Y
    Anticancer Agents Med Chem; 2012 Sep; 12(7):753-63. PubMed ID: 22292750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STUDIES ON QUINOXALINE ANTIBIOTICS. IV. SELECTIVE ANTITUMOR ACTIVITY OF EACH QUINOXALINE ANTIBIOTIC.
    MATSUURA S
    J Antibiot (Tokyo); 1965 Jan; 18():43-6. PubMed ID: 14282372
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cultured human hepatoma cells (BEL-7404) for anticancer drugs screening].
    Yang JL; Shen ZM; Sun YF; Han JX; Xu B
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):144-8. PubMed ID: 3002123
    [No Abstract]   [Full Text] [Related]  

  • 52. Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer.
    Ryschich E; Schmidt E; Maksan SM; Klar E; Schmidt J
    World J Gastroenterol; 2004 Nov; 10(21):3171-4. PubMed ID: 15457566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparative studies on the antigens of three cytoplasmic fractions from the hepatoma and liver of rats. I. Complement fixation test].
    CHEN HY; KU KY; CHEN JM
    Shi Yan Sheng Wu Xue Bao; 1962 Mar; 7():329-41. PubMed ID: 13878625
    [No Abstract]   [Full Text] [Related]  

  • 54. CANCER METASTASIS AND ASCITES TUMORS.
    SATO H
    Natl Cancer Inst Monogr; 1964 Dec; 16():241-61. PubMed ID: 14235656
    [No Abstract]   [Full Text] [Related]  

  • 55. Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.
    Shouval D; Adler R
    Prog Liver Dis; 1993; 11():251-67. PubMed ID: 8272514
    [No Abstract]   [Full Text] [Related]  

  • 56. The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions.
    Yamagata M; Kanematsu T; Matsumata T; Utsunomiya T; Ikeda Y; Sugimachi K
    Eur J Surg Oncol; 1992 Aug; 18(4):379-82. PubMed ID: 1325926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [IMMUNOHISTOCHEMICAL STUDIES OF THE ANTIGENIC DIFFERENCE BETWEEN THE LIVER AND TRANSPLANTED HEPATOMA IN RATS].
    CHENG YS
    Shi Yan Sheng Wu Xue Bao; 1964 Dec; ():311-20. PubMed ID: 14285103
    [No Abstract]   [Full Text] [Related]  

  • 58. PAPER ELECTROPHORETIC STUDIES ON SERUM PROTEINS IN THE DISEASES OF THE DIGESTIVE SYSTEM, WITH PARTICULAR REFERENCE TO THE CHANGES IN SERUM PROTEINS IN THE PATIENTS WITH CANCER.
    KAGEYAMA T
    Bull Osaka Med Sch; 1963 Apr; 9():62-105. PubMed ID: 14152250
    [No Abstract]   [Full Text] [Related]  

  • 59. INHIBITORY EFFECT OF ANTI-CANCER CHEMOTHERAPEUTICS ON LIVER METASTASIS OF INTRAPORTALLY INOCULATED MOUSE ASCITES HEPATOMA.
    KOIZUMI A; YOSHIDA K; TAKAHASHI T; YAMAGUCHI I; MAJIMA S
    Tohoku J Exp Med; 1964 Apr; 82():250-9. PubMed ID: 14166835
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparative studies on the antigens of three cytoplasmic fractions from the hepatoma and liver of rats. II. Anaphylaxis with desensitization].
    KU KY; CHEN HY; CHEN JM
    Shi Yan Sheng Wu Xue Bao; 1962 Mar; 7():342-52. PubMed ID: 14460049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.